CIMG Inc. IPO - What You Need to Know

Thinking about investing in the CIMG Inc. IPO? It is exciting to get in early, but before you invest your money, let’s break down the facts in plain English.

1. What does this company actually do?

CIMG Inc. (formerly NuZee, Inc.) has shifted its focus significantly. They now operate through 13 subsidiaries across the U.S., Hong Kong, Singapore, and China. Their business covers three distinct areas: Maca-based products, health-focused food and medicine, and "computing power" products.

Because the management team is spread across these countries, the company admits that running the business is expensive and operationally difficult. Currently, they earn most of their money from their older health and wellness products, while their new "computing power" segment is still in the early, unproven stages.

2. What is this "Offering" all about?

CIMG is raising money through a "Primary Offering." They are selling up to 900 million "units." Each unit includes one share of stock and one warrant. These warrants give you the right to buy an additional share later at a set price.

The Bitcoin Twist: They are accepting payment in Bitcoin. They aim to raise $13.5 million initially, with a total goal of up to $650 million. They claim Bitcoin helps them diversify their treasury, but they keep it as a "store of value" rather than using it for daily expenses.

3. The "Going Concern" Warning

This is the most important detail: The company’s auditors have raised "substantial doubt" about their ability to stay in business. Simply put, they are losing money. Unless they raise enough cash through this offering, they may not be able to keep the lights on. They have a long history of losses and expect these to continue as they attempt to pivot their business model.

4. The Nasdaq Drama

The company has had a rocky relationship with the Nasdaq. After failing to meet rules—including minimum share price requirements and filing financial reports on time—the Nasdaq delisted them. As of March 2026, their stock was suspended from the Nasdaq and moved to the "OTC" (Over-the-Counter) market. They currently trade on the OTC under the ticker "CIMG." This market is significantly less liquid, less regulated, and more volatile than major exchanges.

5. What are the main risks?

This is a high-risk situation. Beyond the warning about their survival, keep these red flags in mind:

• Speculative Plans: The company admits their future plans are projections, not guarantees. They state that actual results could differ significantly from their estimates due to market volatility.
• Regulatory "Wild Cards": With operations in China and Hong Kong, they face unpredictable government regulations. If local authorities restrict the movement of money, the parent company may be unable to move cash to pay its U.S. obligations.
• Supply Chain Reliance: They rely on a few third-party suppliers. If one partner faces delays or financial trouble, CIMG’s revenue could vanish.
• Liquidity Issues: Being kicked off the Nasdaq makes the stock harder to trade. Furthermore, the warrants they are offering are not listed on any exchange. This creates a "liquidity trap" where you may find it difficult to sell your warrants or turn them into cash.

6. The Bottom Line

This is not a typical IPO. Between the auditor warnings, the history of being delisted, and the complex international structure, this is a highly speculative play. The company is attempting to raise a massive amount of capital to change its business model, but they face a long, difficult road to prove they can be a stable, profitable company.

Before you buy, ask yourself: Am I comfortable investing in a company that its own auditors aren't sure can survive, and that has already lost its spot on a major stock exchange?

Disclaimer: I am an AI, not a financial advisor. This guide is for informational purposes only and does not constitute financial advice. Always do your own research or talk to a professional before making investment decisions.